A clinical trial update wiped out billions in the French company's market cap and raised questions over a potential takeover.
Jefferies downgraded the French biotech to Hold and cut its price target nearly in half, warning the cancer overhang won't ...
Abivax said its experimental treatment for ulcerative colitis showed significant efficacy in a closely watched trial, but ...
A handful of cancer cases reported among treatment recipients overshadowed efficacy results analysts described as ...
Shares in French biotech Abivax tumbled more than 30% today, after it announced phase 3 data with ulcerative colitis (UC) ...
Investor's Business Daily on MSN
Abivax hits 'best-case' scenario for ulcerative colitis drug; so, why did shares plummet?
Abivax stock plummeted Tuesday after several patients developed cancer following a study of its ulcerative colitis treatment.
Our gut is the key to much of our body's overall health, which is why diseases like ulcerative colitis can be so detrimental. Ulcerative colitis is one of the most common inflammatory bowel diseases.
MedPage Today on MSN
IBD and Mental Health: 'The More We Look at This, the Crazier It Gets'
In Crohn's disease/ulcerative colitis, the gut and brain appear to be deeply connected ...
Amebic Colitis is caused by the anaerobic parasitic amoebozoan Entameba histolytica. This bacterium infects the mucosa in the colon and accounts for 100,000 deaths annually. The parasite infects 10% ...
Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD). It causes painful sores and inflammation deep inside your colon and rectum. That can lead to hard-to-manage symptoms like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results